| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |